<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03524079</url>
  </required_header>
  <id_info>
    <org_study_id>RV &amp; BrS</org_study_id>
    <nct_id>NCT03524079</nct_id>
  </id_info>
  <brief_title>Right Ventricle Morphology and Hemodynamics in BrS</brief_title>
  <acronym>RV-BrS</acronym>
  <official_title>Morphological and Functional Characteristics of the Right Ventricle in Patients With Brugada Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Donato</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Donato</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to evaluate the morphological, functional and electrophysiological
      characteristics of the right ventricle before and after ajmaline in patients diagnosed with
      Brugada syndrome as well as to correlate CMR findings and substrate size.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All consecutive patients with suspected BrS-ECG pattern will perform an ajmaline testing
      (1mg/kg in 5 min). A total of 30 patients with positive testing and 30 patients with negative
      testing will be selected and enrolled. Patients will perform cardiac magnetic resonance and
      3D echocardiography imaging to evaluate and compare morphological and functional
      characteristics of the 2 groups before and after ajmaline. Patients with positive testing
      will also perform a standardized programmed ventricular stimulation protocol and
      electroanatomical mapping to determine the substrate size.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Actual">November 9, 2019</completion_date>
  <primary_completion_date type="Actual">November 8, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>echocardiographic parameters changes of the right and left ventricle function</measure>
    <time_frame>1 day during Echocardiography</time_frame>
    <description>Changes of right ejection fraction before and after ajmaline in Brugada patients as compared with control subjects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MRI changes of left and right ventricular function</measure>
    <time_frame>1day during MRI</time_frame>
    <description>MRI changes of left and right ventricular function before and after ajmaline in Brugada patients as compared with control subjects</description>
  </primary_outcome>
  <primary_outcome>
    <measure>echocardiographic parameters changes of the right and left ventricle function</measure>
    <time_frame>1 day during Echocardiography</time_frame>
    <description>Changes of right ventricular areal strain before and after ajmaline in Brugada patients as compared with controls</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Electrical substrate changes of the right ventricle</measure>
    <time_frame>1 day after ICD implantation</time_frame>
    <description>electroanatomical epicardial mapping for substrate determination before and after ajmaline</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Brugada Syndrome</condition>
  <arm_group>
    <arm_group_label>BrS Group</arm_group_label>
    <description>Ajmaline 17-(Chloroacetate) Monohydrochloride</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No BrS group</arm_group_label>
    <description>Ajmaline 17-(Chloroacetate) Monohydrochloride</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ajmaline 17-(Chloroacetate) Monohydrochloride</intervention_name>
    <description>Ajmaline 17-(Chloroacetate) Monohydrochloride(1mg/kg in 5 minutes)</description>
    <arm_group_label>BrS Group</arm_group_label>
    <arm_group_label>No BrS group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 60 selected subjects (30 patients with positive ajmaline testing and 30 with
        negative testing) will be enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspicious Brugada syndrome

          -  Indication to ajmaline testing and programmed ventricular stimulation

          -  Age &gt; or equal to 18 years

          -  Written informed consent

        Exclusion Criteria:

          -  Pregnancy

          -  Contraindication to CMRI or to ajmaline

          -  Live espectance &lt; 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Pappone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS San Donato University Hospital Policlinico San Donato, Milan, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS Policlinico S. Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <state>Milano</state>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 19, 2018</study_first_submitted>
  <study_first_submitted_qc>May 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2018</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Donato</investigator_affiliation>
    <investigator_full_name>Carlo Pappone</investigator_full_name>
    <investigator_title>Head of Arrhythmology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brugada Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ajmaline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

